Chronic Thromboembolic Pulmonary Hypertension clinical trials at UCSD
1 research study open to eligible people
Showing trials for
A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
open to eligible people ages 18-80
The purpose of the study is to evaluate the effect of macitentan 75 mg versus placebo on exercise capacity at Week 28 in participants with chronic thromboembolic pulmonary hypertension (CTEPH).
La Jolla, California and other locations
Last updated: